We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.

Kindr Research · Open dataset · CC-BY 4.0

The menopause clinical trial gap (2026 update)

Share of NIH-funded and industry-sponsored clinical trials investigating menopause vs. comparably prevalent men’s health conditions.

<1%
NIH budget on menopause
5:1
Men's vs women's midlife trial ratio
284
Active menopause trials (US)

Key findings

Methodology

Kindr Research assembles this dataset from three sources: (1) peer-reviewed literature identified via PubMed and Cochrane, (2) de-identified aggregate signals from Kindr Health clinical operations, and (3) publicly available datasets (CDC, NHANES, SWAN, HCUP, CMS). Confidence intervals reflect underlying study heterogeneity. Ranges are reported at 95% CI where source data permits. This report was reviewed by the Kindr Health Clinical Team prior to publication. It is not intended as medical advice; consult a licensed clinician for individual guidance.

Sources

  1. North American Menopause Society (NAMS) 2022 Position Statement on Hormone Therapy
  2. ACOG — Committee Opinion on Hormone Therapy
  3. Endocrine Society clinical practice guidelines
  4. CDC HCUP — Healthcare Cost and Utilization Project
  5. SWAN — Study of Women's Health Across the Nation

More Kindr Research: Lifespan Manual · Menopause Data Hub · All research.

Ask Dot